CYTK
Price
$37.14
Change
-$0.17 (-0.46%)
Updated
Jul 25, 04:59 PM (EDT)
Capitalization
4.44B
5 days until earnings call
ROIV
Price
$11.54
Change
+$0.17 (+1.49%)
Updated
Jul 25, 04:59 PM (EDT)
Capitalization
7.85B
23 days until earnings call
Interact to see
Advertisement

CYTK vs ROIV

Header iconCYTK vs ROIV Comparison
Open Charts CYTK vs ROIVBanner chart's image
Cytokinetics
Price$37.14
Change-$0.17 (-0.46%)
Volume$18.24K
Capitalization4.44B
Roivant Sciences
Price$11.54
Change+$0.17 (+1.49%)
Volume$58.89K
Capitalization7.85B
CYTK vs ROIV Comparison Chart in %
Loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYTK vs. ROIV commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a Hold and ROIV is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (CYTK: $37.18 vs. ROIV: $11.55)
Brand notoriety: CYTK and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTK: 73% vs. ROIV: 69%
Market capitalization -- CYTK: $4.44B vs. ROIV: $7.85B
CYTK [@Biotechnology] is valued at $4.44B. ROIV’s [@Biotechnology] market capitalization is $7.85B. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTK’s FA Score shows that 1 FA rating(s) are green whileROIV’s FA Score has 0 green FA rating(s).

  • CYTK’s FA Score: 1 green, 4 red.
  • ROIV’s FA Score: 0 green, 5 red.
According to our system of comparison, CYTK is a better buy in the long-term than ROIV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTK’s TA Score shows that 5 TA indicator(s) are bullish while ROIV’s TA Score has 8 bullish TA indicator(s).

  • CYTK’s TA Score: 5 bullish, 5 bearish.
  • ROIV’s TA Score: 8 bullish, 2 bearish.
According to our system of comparison, ROIV is a better buy in the short-term than CYTK.

Price Growth

CYTK (@Biotechnology) experienced а -0.13% price change this week, while ROIV (@Biotechnology) price change was +0.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

CYTK is expected to report earnings on Oct 30, 2025.

ROIV is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($7.85B) has a higher market cap than CYTK($4.44B). ROIV YTD gains are higher at: -2.367 vs. CYTK (-20.961). CYTK has higher annual earnings (EBITDA): -513.62M vs. ROIV (-1.1B). ROIV has more cash in the bank: 4.89B vs. CYTK (938M). ROIV has less debt than CYTK: ROIV (100M) vs CYTK (791M). ROIV has higher revenues than CYTK: ROIV (29.1M) vs CYTK (19.2M).
CYTKROIVCYTK / ROIV
Capitalization4.44B7.85B57%
EBITDA-513.62M-1.1B47%
Gain YTD-20.961-2.367886%
P/E RatioN/A1.97-
Revenue19.2M29.1M66%
Total Cash938M4.89B19%
Total Debt791M100M791%
FUNDAMENTALS RATINGS
CYTK: Fundamental Ratings
CYTK
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
83
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYTKROIV
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
73%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
62%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
71%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 4 days ago
71%
Declines
ODDS (%)
Bearish Trend 5 days ago
77%
Bearish Trend 2 days ago
72%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
70%
Aroon
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GESOX19.360.03
+0.16%
Lazard Global Equity Select Port Open
ALVSX11.07N/A
N/A
American Century Focused Lg Cap Val I
LSCRX21.80N/A
N/A
Loomis Sayles Small Cap Value Retail
VMGMX125.08N/A
N/A
Vanguard Mid-Cap Growth Index Admiral
VYRIX12.84N/A
N/A
VY® T. Rowe Price Divers Mid Cap Gr R6

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
+1.49%
IMVT - ROIV
60%
Loosely correlated
-7.48%
ACLX - ROIV
53%
Loosely correlated
+1.48%
KRYS - ROIV
52%
Loosely correlated
-1.59%
CRNX - ROIV
52%
Loosely correlated
+1.91%
CGON - ROIV
50%
Loosely correlated
-0.15%
More